Anesthesia and Intensive Care Department, Humanitas Gavazzeni Clinic, Bergamo, Italy.
Department of Anesthesia and Intensive Care, Cardiothoracic Center, Istituto Clinico Sant'Ambrogio, Milano, Italy; Chair of Cardiac Surgery, University of Milan, Milano, Italy.
J Cardiothorac Vasc Anesth. 2020 Jan;34(1):119-127. doi: 10.1053/j.jvca.2019.06.030. Epub 2019 Jun 28.
Postoperative hemorrhage in cardiac surgery is a significant cause of morbidity and mortality. Standard laboratory tests fail as predictors for bleeding in the surgical setting. The use of viscoelastic (VE) hemostatic assays thromboelastography (TEG) and rotational thromboelastometry (ROTEM) could be an advantage in patients undergoing cardiac surgery. The objective of this meta-analysis was to analyze the effects (benefits and harms) of VE-guided transfusion practice in cardiac surgery patients.
A meta-analysis of randomized trials.
For this study, PubMed, EMBASE, Scopus, and the Cochrane Collaboration database were searched, and only randomized controlled trials were included. A systematic review and meta-analysis were performed in accordance with the standards set forth by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, using a random-effects model.
The study comprised adult cardiac surgery patients.
VE-hemostatic assays transfusion algorithm compared with transfusion algorithms based on clinicians' discretion.
Seven comparative randomized controlled trials were considered, including a total of 1,035 patients (522 patients in whom a TEG- or ROTEM-based transfusion algorithm was used). In patients treated according to VE-guided algorithms, red blood cell (odds ratio 0.61; 95% confidence interval [CI]: 0.37-0.99; p: 0.04; I: 66%) and fresh frozen plasma transfusions (risk difference 0.22; 95% CI: 0.11-0.33; p < 0.0001; I: 79%) use was reduced; platelets transfusion was not reduced (odds ratio 0.61; 95% CI: 0.32-1.15; p: 0.12; I 74%).
This study demonstrated that the use of VE assays in cardiac surgical patients is effective in reducing allogenic blood products exposure, postoperative bleeding at 12 and 24 hours after surgery, and the need for redo surgery unrelated to surgical bleeding.
心脏手术后出血是发病率和死亡率的重要原因。标准实验室检测在手术环境中不能预测出血。使用黏弹性(VE)止血测定法血栓弹性描记术(TEG)和旋转血栓弹性描记法(ROTEM)可能对接受心脏手术的患者有利。本荟萃分析的目的是分析 VE 指导输血实践对心脏手术患者的影响(益处和危害)。
随机试验的荟萃分析。
为了进行这项研究,检索了 PubMed、EMBASE、Scopus 和 Cochrane 协作数据库,只纳入了随机对照试验。根据系统评价和荟萃分析的首选报告项目声明的标准进行了系统评价和荟萃分析,使用随机效应模型。
研究包括成年心脏手术患者。
VE 止血测定法输血算法与基于临床医生判断的输血算法进行比较。
考虑了 7 项比较性随机对照试验,共纳入 1035 例患者(522 例接受 TEG 或 ROTEM 为基础的输血算法治疗)。在根据 VE 指导算法治疗的患者中,红细胞(比值比 0.61;95%置信区间 [CI]:0.37-0.99;p:0.04;I:66%)和新鲜冷冻血浆输注(差异风险 0.22;95%CI:0.11-0.33;p<0.0001;I:79%)减少;血小板输注未减少(比值比 0.61;95%CI:0.32-1.15;p:0.12;I:74%)。
本研究表明,VE 检测在心脏外科患者中的应用可有效减少同种异体血液制品的暴露,术后 12 小时和 24 小时的出血,以及与手术出血无关的再次手术需求。